Relay Therapeutics Inc — Cash Flow (NASDAQ:RLAY)

Financials

Cash from operating activities -102.49 M-74.41 M-229.49 M-300.32 M-249.11 M-235.46 M -235.46 M Cash from investing activities 81.67 M-479.51 M-188.75 M257.63 M-41.08 M192.8 M 192.8 M Cash from financing activities 426.51 M388.09 M289.91 M34.75 M270.15 M1.6 M — Free cash flow -104.42 M-77.88 M-238.55 M-304.44 M-251.13 M-235.87 M -235.87 M

Haberler

Relay Therapeutics CFO’su 257 bin dolarlık hisse sattı

Relay Therapeutics hissesi 14,98 dolarda zirve yaptı

Relay Therapeutics hissesi 11,52 dolarla zirve yaptı

H.C. Wainwright, Relay Therapeutics için hedef fiyatı yükseltti

Raymond James, Relay Therapeutics hissesi için Güçlü Al tavsiyesini yineledi

Oppenheimer, deneme verileri sonrası Relay hisse notunu korudu

Oppenheimer reiterates Relay Therapeutics stock rating on trial data

Relay, meme kanseri ilacı için faz 1/2 verilerini açıkladı

Relay reports phase 1/2 data for breast cancer drug zovegalisib

Guggenheim, Relay Therapeutics için hedef fiyatı yükseltti

Guggenheim raises Relay Therapeutics price target on VM opportunity

Relay Therapeutics (RLAY) Soars 5.4%: Is Further Upside Left in the Stock?